Prolongation of Repolarization as Antifibrillatory Action Revisited: Drug Combination Therapy in Atrial Fibrillation

Singh BN , Vaughan Williams EM . A third class of antiarrhythmic action. Effects on atrial and ventricular intracellular potentials, and other pharmacological actions on cardiac muscle, of MJ 1999 and AH 3474. Br J Pharmacol 39:675-687, 1970

Singh BN , Vaughan Williams . The effect of amiodarone, a new anti-anginal drug, cardiac muscle. Br J Pharmacol 39:657-667, 1970

Singh BN. Pharmacological actions of certain cardiac drugs and hormones: Focus on antiarrhythmic mechanisms. D. Phil. Thesis, 1971; Hertford College & University of Oxford, England. Published also by Futura Publishing Co, Mt Kisco, NY, pp 1-98, 1991

Pritchard DA , Singh BN , Hurley P . Effect of amiodarone on thyroid function in patients with ischemic heart disease. Br Heart J 37:856-860, 1975

Rosenbaum MB , Chiale PA , Halern MS , et al . Clinical efficacy of amiodarone as an antiarrhythmic drug. Am J Cardiol 34:215-223, 1976

Singh BN . Antiarrhythmic actions of amiodarone: A profile of a paradoxical agent. Am J Cardiol 78:41-53, 1996

Connolly SJ . Evidence based-analysis of amiodarone efficacy and safety. Circulation 100:2025-2034, 1999

Nattel S , Singh BN . Evolution, mechanisms, and classification of antiarrhythmic drugs: Focus on class III actions. Am J Cardiol 84 (9A):11-19, 1999

Singh BN . The coming of age of class III antiarrhythmic principle: Retrospective and future trends. Am J Cardiol 78(Suppl 4a):17-27, 1996

Lazzara R . From first class to third class: Recent upheaval in antiarrhythmic therapy—lessons from clinical trials. Am J Cardiol 78:28-33, 1996

Torp-Pedersen C , Moller M , Bloch-Thomsen PE , et al . For the Danish Investigations of Arrhythmia and Mortality on Dofetilide Study Group . Dofetilide in patients with congestive heart failure and left ventricular dysfunction. N Engl J Med 341:857-865, 1999

Murray KT . Ibutilide. Circulation 97:493-497, 1999

Waldo AL , Camm AJ , deRuyter H , et al . Effects of d-stall on mortality in patients with left ventricular dysfunction after recent and remote myocardial. Lancet 348:7-12, 1996

Nagra BS , Ledley GS , Kantharia BK . Marked QT prolongation and Torsades de Pointes secondary to acute myocardial ischemia in an elderly man taking dofetlide for atrial fibrillation: A cautionary tail. J Cardiovac Pharmacol Therapeut (2005; in press)

Singh BN , Kowey PR . Evidence and Potential: Beta-blockers as antiarrhythmic agents in the patient with cardiovascular disease. J Cardiovasc Pharmacol Therapeut 10(Suppl 1):S1-S68, 2005

Singh BN . β-Adrenergic blockers as antiarrhythmic and antifibrillatory compounds: An overview. Disease. J Cardiovasc Pharmacol Therapeut 10(Suppl 1):S3-S14, 2005

Naccarelli GV . Anti-adrenergic therapy in the control of atrial fibrillation. J Cardiovasc Pharmacol Therapeut 10(Suppl 1):S33-S43, 2005

Singh BN , Singh SN , Reda DJ , Tang XC , et al . Amiodarone versus sotalol for atrial fibrillation. N Engl J Med 352:1861-1872, 2005

Benditt DG , Williams JH , Jin J , et al . Maintenance of sinus rhythm with oral dl-sotalol therapy in patients with symptomatic atrial fibrillation and/or atrial flutter. Am J Cardiol 84:270-277, 1999

Roy D , Talajic M , Dorian P , et al for the Canadian Trial of Atrial Fibrillation Investigators . Amiodarone to prevent recurrence of atrial fibrillation. N Engl J Med 342:913-918, 2000

Singh BN . Searching for the ideal class III antiarrhythmic agent: How pure should they be? J Cardiovasc Pharmacol Therapeut 2(4):239-242, 1997

CAPRICORN Investigators . Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: The CAPRICORN randomized trial. Lancet 357:1385-1390, 2001

Kuhlkamp V , Schirdewan A , Strangl K , et al . Use of metoprolol of CR/XL to maintain sinus rhythm after conversion from persistent atrial fibrillation. Randomized, double-blind, placebo-controlled study. J Am Coll Cardiol 36:139-146, 2000

Pedersen OD , Bagger H , Kober L , et al . Trandolapril reduces the incidence of atrial fibrillation after acute myocardial in patients with left ventricular dysfunction. Circulation 106:331-336, 2002

Kanoupakis EM , Manio EG , Mavkaris , et al . Effects of carvedilol and amiodarone on persistent atrial fibrillation conversion and recurrence rates. A randomized controlled study. Am J Cardiol 94:659-662, 2004

Madrid AH , Bueno MG , Rerboll JMG , et al . Use of irbesaran to maintain sinus rhythm in patients with long-lasting persistent atrial fibrillation. A prospective and randomized study. Circulation 106:331-336, 2002